SCHEMBL15280

SCHEMBL15280

CC(C)CC(C#N)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RNPEP Q9H4A4 1/20 0.44
SLC7A5 Q01650 1/20 0.44
ALDH1A1 P00352 2/20 0.39
SLC1A3 P43003 1/20 0.39
SLC1A2 P43004 1/20 0.39
CPA1 P15085 2/20 0.36
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36
KMT2A Q03164 1/20 0.36
CTSS P25774 1/20 0.35
CTSK P43235 1/20 0.35
CACNA2D1 P54289 2/20 0.34
CACNB3 P54284 1/20 0.34
CACNA1C Q13936 1/20 0.34
PGR P06401 1/20 0.34
ADRA1A P35348 1/20 0.34
HTR2B P41595 1/20 0.34
CACNA2D2 Q9NY47 1/20 0.34
MAPT P10636 1/20 0.34
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1305300 0.85 SLC1A2 (0.35) SLC1A3SLC1A2
SCHEMBL24484306 0.81 ALDH1A1 (0.35) RNPEPSLC7A5ALDH1A1SLC1A3SLC1A2
SCHEMBL3917719 0.81 SLC7A5 (0.39) RNPEPSLC7A5ALDH1A1SLC1A3SLC1A2
SCHEMBL474799 0.80 RNPEP (0.31) RNPEPSLC7A5
SCHEMBL865611 0.80 RNPEP (0.31) RNPEPSLC7A5
SCHEMBL1419497 0.79 SLC1A3 (0.39) RNPEPSLC7A5SLC1A3SLC1A2ADRA1A
Ammonia Solution, Strong SCHEMBL15240120 0.79 RNPEP (0.30) RNPEPSLC7A5
Ammonia Solution, Strong SCHEMBL15240116 0.79 RNPEP (0.30) RNPEPSLC7A5
SCHEMBL4338846 0.77 SLC1A3 (0.38) RNPEPSLC7A5SLC1A3SLC1A2ADRA1A
SCHEMBL21436746 0.77 RNPEP (0.41) RNPEPSLC7A5ALDH1A1SLC1A3SLC1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2268589-B1 SIZING COMPOSITION FOR MINERAL FIBERS AND RESULTING PRODUCTS SAINT GOBAIN ISOVER (FR) 2018-06-13 EP claimed
EP-2438025-B1 MINERAL FIBER MAT CONTAINING A FORMALDEHYDE-TRAPPING AGENT, AND METHODS FOR MANUFACTURING SAME SAINT-GOBAIN ADFORS (FR) 2017-12-27 EP claimed
EP-2349944-B1 PROCESS FOR MANUFACTURING INSULATION PRODUCTS BASED ON MINERAL WOOL, AND PRODUCTS OBTAINED SAINT GOBAIN ISOVER (FR) 2017-05-17 EP claimed
EP-2379465-B1 PAINTER'S CANVAS INCLUDING AN AGENT CAPABLE OF TRAPPING FORMALDEHYDE AND MANUFACTURING PROCESS SAINT GOBAIN ADFORS (FR) 2013-01-02 EP claimed
EP-2496649-A1 FILM-FORMING COMPOSITION CONTAINING AN AGENT CAPABLE OF TRAPPING FORMALDEHYDE Saint-Gobain Adfors (FR) 2012-09-12 EP claimed
WO-2011141923-A2 IMPROVED SYNTHESIS OF OPTICALLY PURE (S) - 3-CYANO-5-METHYL-HEXANOIC ACID ALKYL ESTER, AN INTERMEDIATE OF (S)- PREGABALIN LUPIN LIMITED (IN) 2011-11-17 WO claimed
US-20110272621-A1 PROCESS FOR MANUFACTURING INSULATION PRODUCTS BASED ON MINERAL WOOL, AND PRODUCTS OBTAINED SAINT-GOBAIN ISOVER (FR) 2011-11-10 US claimed
EP-2379465-A2 PAINTER'S CANVAS INCLUDING AN AGENT CAPABLE OF TRAPPING FORMALDEHYDE AND MANUFACTURING PROCESS Saint-Gobain Adfors (FR) 2011-10-26 EP claimed
EP-2349944-A1 PROCESS FOR MANUFACTURING INSULATION PRODUCTS BASED ON MINERAL WOOL, AND PRODUCTS OBTAINED Saint-Gobain Isover (FR) 2011-08-03 EP claimed
WO-2011055073-A1 FILM-FORMING COMPOSITION CONTAINING AN AGENT CAPABLE OF TRAPPING FORMALDEHYDE SAINT-GOBAIN TECHNICAL FABRICS EUROPE (FR) 2011-05-12 WO claimed
US-20110111226-A1 SIZING COMPOSITION FOR MINERAL FIBERS AND RESULTING PRODUCTS SAINT- GOBAIN ISOVER (FR) 2011-05-12 US claimed
EP-2268589-A2 SIZING COMPOSITION FOR MINERAL FIBERS AND RESULTING PRODUCTS Saint-Gobain Isover (FR) 2011-01-05 EP claimed
WO-2010139897-A1 MINERAL FIBER MAT CONTAINING A FORMALDEHYDE-TRAPPING AGENT, AND METHODS FOR MANUFACTURING SAME SAINT-GOBAIN TECHNICAL FABRICS EUROPE (FR) 2010-12-09 WO claimed
WO-2010070248-A2 PAINTER'S CANVAS INCLUDING AN AGENT CAPABLE OF TRAPPING FORMALDEHYDE AND MANUFACTURING PROCESS SAINT-GOBAIN TECHNICAL FABRICS EUROPE (FR) 2010-06-24 WO claimed
WO-2010040963-A1 PROCESS FOR MANUFACTURING INSULATION PRODUCTS BASED ON MINERAL WOOL, AND PRODUCTS OBTAINED SAINT-GOBAIN ISOVER (FR) 2010-04-15 WO claimed
WO-2009136105-A2 SIZING COMPOSITION FOR MINERAL FIBERS AND RESULTING PRODUCTS SAINT-GOBAIN ISOVER (FR) 2009-11-12 WO claimed
EP-0938509-B1 COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS BASELL POLIOLEFINE SPA (IT) 2002-11-20 EP claimed
US-20250304529-A1 BIOBASED CYANOACRYLATE COMPOUND BOSTIK SA (FR) 2025-10-02 US disclosed
EP-0938509-A1 COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS Montell Technology Company bv (NL) 1999-09-01 EP disclosed
WO-1999011677-A1 COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS MONTELL TECHNOLOGY COMPANY B.V. (NL) 1999-03-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250304529-A1 BIOBASED CYANOACRYLATE COMPOUND BAP1, CBR1, CBR3 RNPEP 2929/4885SLC7A5 4458/4885ALDH1A1 95/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.